Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 27;11(1):37.
doi: 10.1186/s13613-021-00825-5.

High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study

Nicolas Bonnet  1   2 , Olivier Martin  3   4 , Marouane Boubaya  5 , Vincent Levy  5   4 , Nathan Ebstein  3   4 , Philippe Karoubi  6 , Yacine Tandjaoui-Lambiotte  3   7 , Guillaume Van Der Meersch  3 , Johanna Oziel  3 , Marie Soulie  3 , Mohamed Ghalayini  3 , Anais Winchenne  3 , Jean Ralph Zahar  8   4 , Passem Ahmed  6 , Stéphane Gaudry  3   4   9 , Yves Cohen  3   4   10
Affiliations

High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study

Nicolas Bonnet et al. Ann Intensive Care. .

Abstract

Background: The efficacy of high flow nasal canula oxygen therapy (HFNO) to prevent invasive mechanical ventilation (IMV) is not well established in severe coronavirus disease 2019 (COVID-19). The aim of this study was to compare the risk of IMV between two strategies of oxygenation (conventional oxygenation and HFNO) in critically ill COVID 19 patients.

Methods: This was a bicenter retrospective study which took place in two intensive care units (ICU) of tertiary hospitals in the Paris region from March 11, to May 3, 2020. We enrolled consecutive patients hospitalized for COVID-19 and acute respiratory failure (ARF) who did not receive IMV at ICU admission. The primary outcome was the rate of IMV after ICU admission. Secondary outcomes were death at day 28 and day 60, length of ICU stay and ventilator-free days at day 28. Data from the HFNO group were compared with those from the standard oxygen therapy (SOT) group using weighted propensity score.

Results: Among 138 patients who met the inclusion criteria, 62 (45%) were treated with SOT alone, and 76 (55%) with HFNO. In HFNO group, 39/76 (51%) patients received IMV and 46/62 (74%) in SOT group (OR 0.37 [95% CI, 0.18-0.76] p = 0.007). After weighted propensity score, HFNO was still associated with a lower rate of IMV (OR 0.31 [95% CI, 0.14-0.66] p = 0.002). Length of ICU stay and mortality at day 28 and day 60 did not significantly differ between HFNO and SOT groups after weighted propensity score. Ventilator-free days at days 28 was higher in HNFO group (21 days vs 10 days, p = 0.005). In the HFNO group, predictive factors associated with IMV were SAPS2 score (OR 1.13 [95%CI, 1.06-1.20] p = 0.0002) and ROX index > 4.88 (OR 0.23 [95%CI, 0.008-0.64] p = 0.006).

Conclusions: High flow nasal canula oxygen for ARF due to COVID-19 is associated with a lower rate of invasive mechanical ventilation.

Keywords: Acute respiratory failure; COVID-19; High flow nasal canula; Intensive care unit.

PubMed Disclaimer

Conflict of interest statement

JRZ reports personal fees from Pfizer, personal fees from Correvio, personal fees from Eumedica, personal fees from Merck Sharp and Dohme, outside the submitted work. NB, OM, MB, VL, NE, PK, YTL, GVDM, JO, MS, MG, AW, PA, SG ang YC report no conflict of interest.

Figures

Fig. 1
Fig. 1
Flow chart. NIV non-invasive mechanical ventilation, ICU Intensive Care Unit, HFNO High Flow Nasal Canula Oxygen
Fig. 2
Fig. 2
Mean difference of covariate balances before and after weighting
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan China. JAMA Am Med Assoc. 2020;323:1061–1069. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed
    1. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region. Italy JAMA American Medical Association. 2020;323:1574–1581. doi: 10.1001/jama.2020.5394. - DOI - PMC - PubMed
    1. Frat J-P, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185–2196. doi: 10.1056/NEJMoa1503326. - DOI - PubMed
    1. Demoule A, Vieillard Baron A, Darmon M, Beurton A, Géri G, Voiriot G, et al. High flow nasal canula in critically ill severe COVID-19 patients. Am J Respir Crit Care Med. 2020. - PMC - PubMed
    1. Cheung JC-H, Ho LT, Cheng JV, Cham EYK, Lam KN. Staff safety during emergency airway management for COVID-19 in Hong Kong. Lancet Respir Med. 2020; 8: e19. - PMC - PubMed

LinkOut - more resources